Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:  The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated savings and operational benefits from the asset realignment;  Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;  Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;  An inability to raise or sustain prices for products or services;  An inability to maintain appropriate relations with unions and employees;  The inability to achieve expected results from our acquisition activities;  Our ability to continue to pay cash dividends;  The amount and timing of repurchases of our common shares, if any; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation. • The above list of factors is not exhaustive. • We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. Use of Non-GAAP Measures Page 3 -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&P 500 Page 4 All time high of $32.32 October 21st, 2013 • 16 consecutive quarters of double digit EPS growth • 42% CAGR adjusted EPS expansion 2006-2012 • YTD stock price has increased 56% versus 22% growth in the S&P • Six fold increase in market cap: $0.5b $3.0b Strategy and Execution Drive Results PP&S 15% Specialty 60% Distribution 25% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010* 2011* 2012* 2015 Target Ad ju st ed E ar ni ng s P er S ha re Appliance 6% Building & Construction 13% Wire & Cable Electrical & Electronics 4% Consumer Packaging 18% Industrial 10% Misc. 5% HealthCare Transportation 16% Textiles 1% United States 70% Europe 14% Canada 8% Asia 5% Latin America 3% 2012 Revenues: $4.0 Billion* End Markets* 2012 Revenues: $4.0 Billion* EPS Page 5 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations PolyOne At A Glance * Restated to exclude discontinued operations Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 63% 65- 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 YTD 2013 2015 % o f O pe ra tin g In co m e* JV's PP&S Distribution Specialty Specialty OI $5M $46M $87M $153M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 6 2006 YTD 2013 2015 Where we were Where we are Organic Consolidated Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 12.8% 12.8% 12 – 16% Global Specialty Engineered Materials 1.1% 10.8% 8.9% 12 – 16% Designed Structures & Solutions — — 5.0% 8 – 10% Performance Products & Solutions 5.5% 8.0% 8.2% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 63% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 28% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 7 *Percentage of Specialty Platform revenue from products introduced in last five years 19.5% 44.0% 2006 Q3 2013 $20.3 $46.6 2006 TTM Q3'13 14.3% 31.0% 2006 Q3 2013 Research & Development Spending Specialty Platform Vitality Index Progression* Innovation Drives Earnings Growth ($ millions) Specialty Platform Gross Margin % Page 8 We are Experts in Polymer Science and Formulation  Polymer Science  Formulation  Chemistry  Processing Inputs  Base Resins  Additives  Modifiers  Colorants Specialized Polymer Materials, Services, and Solutions Expertise Satisfied Consumers PolyOne Customer Innovative Products & Services  Marketplace Demands  Performance Requirements  Value Drivers Page 9 Positioned for Strong Growth 2015 Target Rev: $5B Adj. Average Debt Q3 2012 Q4 2012 Q1 2013 Q2 2013 Q3 2013 Average PolyOne Debt $ 705.2 $ 706.9 $ 1,055.5 $ 1,031.2 $ 987.7 $ 897.3 Average Equity Q3 2012 Q4 2012 Q1 2013 Q2 2013 Q3 2013 Average PolyOne shareholders’ equity $ 629.3 $ 629.1 $ 871.8 $ 993.9 $ 996.6 $ 824.1 Reconciliation to Condensed Consolidated Balance Sheets YTD 2013 Short-term debt and current portion of long-term debt $ 9.9 Long-term debt 977.8 Less cash and cash equivalents (322.8) Net debt $ 664.9 Adjusted EBITDA Q4 2012 Q1 2013 Q2 2013 Q3 2013 Total PolyOne Income before income taxes $ (1.1) $ 15.7 $ 62.9 $ 38.8 $ 116.3 PolyOne Interest expense, net 13.7 15.6 16.6 16.0 61.9 PolyOne Depreciation and amortization 15.5 19.0 25.8 30.3 90.6 PolyOne Special items in EBITDA 26.5 27.7 (5.2) 11.2 60.2 PolyOne Adjusted EBITDA 54.6 78.0 100.1 96.3 329.0 Pro forma Spartech EBITDA 14.7 11.2 - - 25.9 Pro forma EBITDA $ 69.3 $ 89.2 $ 100.1 $ 96.3 $ 354.9 CFA Society Cleveland �Midwest Investment Conference 2013��PolyOne Investor Presentation �November 19, 2013� Forward – Looking Statements Use of Non-GAAP Measures Strategy and Execution Drive Results PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Proof of Performance & 2015 Goals Innovation Drives Earnings Growth We are Experts in Polymer Science and Formulation Positioned for Strong Growth Q3 2013 Financial Highlights Debt Maturities & Liquidity Summary – 9/30/13 Use of Cash Why Invest In PolyOne?

5G Applications We help you select the optimal polymer system for your specific application. More Carbon Fiber Composites Strong, lightweight alternative for metal and wood applications More Laser Marking Made Simple Learn how you can achieve permanent results with laser marking additives.

A leading North American manufacturer of polypropylene (PP) hose for medical applications, including laser surgery, respiratory care and sleep apnea equipment, faced a challenge with its existing thermoplastic vulcanizate (TPV). The Avient team assessed the application’s technical and operational requirements, and recommended a GLS™ Versalloy™ alloy in 45 Shore A durometer, an FDA-compliant medical TPV grade designed for overmolding onto PP. With Avient’s assistance and experience in medical device applications, the manufacturer immediately realized the following lifts:

From resin formulations to composite matrix and fiber configurations, we can help you develop the combination that will meet your specific needs. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.

Application-based material recommendations: PolyOne’s distribution team works with medical device customers to discover an outstanding combination of resources, technology expertise and material solutions to meet application needs. With a comprehensive distribution portfolio of clear rigid, opaque rigid, and flexible medical-grade polymers, PolyOne is uniquely equipped to help healthcare customers navigate the material selection process, whether an application requires a single material or multiple polymers.

Avient Corporation will highlight Hydrocerol™ Chemical Foaming Agents, which can be used to reduce weight in automotive applications such as door panels, at the Plastics in Automotive Engineering (PIAE) Conference 2024 The two-day conference, which takes place at the Rosengarten Center in Mannheim, brings together global automotive plastics experts interested in using plastics in interior, exterior, and under-the-hood vehicle applications. Dyneema®, the world’s strongest fiber™, enables unmatched levels of performance and protection for end-use applications, including ballistic personal protection, marine and sustainable infrastructure and outdoor sports  

It currently includes more than a dozen pages dedicated to the different sectors and industries Dyneema® serves, 20 pages aimed at downstream audiences looking for content about end-use applications and products, and seven pages providing system designers and engineers with insights into the technical properties and versatility of Dyneema® materials. Formed from two Greek words meaning “strong” and “fiber,” the name Dyneema® has become a byword for strength in applications and industries worldwide. Dyneema®, the world’s strongest fiber™, which enables unmatched levels of performance and protection for end-use applications, including ballistic personal protection, marine and sustainable infrastructure, and outdoor sports  

Within these two areas, there are a handful of different application methods used to incorporate a security authentication solution into a product. These covert solutions are ideal for packaging applications where the field is heavily text or graphic laden. Polymer-based solutions are ideal for applications where durability is a concern and there is a need to verify the authenticity of the item after the initial sales, for instance in a warranty claim or litigation following product use.

GLOBAL VACUUM CLEANER BRAND B A T T E R Y P A C K & C O V E R • Flame retardance to conform to UL 94 V-0 at 0.75 mm • Easy to process and high-flow material to meet thin wall part design • Offered a UL 94 V-0 certified material to fulfill specific customer requests • Achieved excellent impact strength and good flexural modulus for added durability • Delivered an injection moldable PP with high flow to meet thin-wall demands Maxxam™ FR Flame Retardant Polyolefin Formulations KEY REQUIREMENTS WHY AVIENT? https://www.avient.com/products/engineered-polymer-formulations/flame-retardant-formulations/maxxam-fr-flame-retardant-polyolefin-formulations

SBD CORDLESS POWER TOOL B A T T E R Y P A C K • PA66-based solution • Meet flame retardant UL94 V-0 standard • Pass 10-meter drop test • Achieved flame retardance of UL94 V-0 rating @1.5 and 3.0 mm, GWFI 750 °C • Offered material and high impact with good laser marking performance strength • Accomplished excellent surface appearance with less visible fibers • Provided shorter lead time and stronger technical support than the competition Bergamid™ FR Non-Halogen Flame Retardant Formulation KEY REQUIREMENTS WHY AVIENT? LEARN MORE https://www.avient.com/products/engineered-polymer-formulations/flame-retardant-formulations/bergamid-fr-non-halogen-flame-retardant-formulations